David Patel
Persistent atrial fibrillation with symptomatic palpitations, exercise intolerance, and an elevated CHA₂DS₂-VASc score of 3 warranting anticoagulation. David failed two attempts at pharmacological cardioversion and remained in AF despite rate control with bisoprolol. He was referred for pulmonary vein isolation via radiofrequency catheter ablation after a detailed electrophysiology assessment confirmed persistent AF with left atrial dilatation on echocardiography.
David Patel had lived with an irregular heartbeat for two years before anyone found the right solution. At fifty years old, the IT consultant had been experiencing episodes of racing, fluttering palpitations that left him breathless and unable to concentrate. Multiple attempts to correct the rhythm with medication had failed, and his quality of life had declined sharply. He was struggling to climb stairs without becoming winded, had given up his weekly football coaching sessions, and was increasingly anxious about what was happening inside his chest. When he was referred to the cardiac electrophysiology service at Silvaris Heart & Vascular in Columbus, he arrived cautiously optimistic.
The electrophysiology team carried out a thorough assessment — echocardiogram, Holter monitoring, and a detailed review of his arrhythmia history — before recommending pulmonary vein isolation, a catheter ablation procedure targeting the electrical triggers of his atrial fibrillation. His cardiologist explained the procedure in detail, including the success rates, the small risk of complications, and what to expect during the recovery period. David appreciated the transparency. "He told me it wasn't a guaranteed cure," he recalls. "But he explained that most people in my situation experienced a significant improvement, and for many it was transformative. That honesty gave me confidence rather than false hope."
The ablation procedure was performed under general anaesthesia and lasted approximately four hours. David was monitored overnight and discharged the following morning with a clear written plan for medication management, activity restrictions, and follow-up appointments. The first six weeks involved some return of palpitations — a normal part of the healing process, he had been forewarned — which his cardiologist managed by phone consultation, adjusting his medication without requiring an unplanned visit. "The access to the team between appointments was really reassuring," David says. "Knowing I could reach someone who knew my case when I was worried made an enormous difference."
At his three-month review, a seven-day cardiac monitor confirmed the outcome his team had been hoping for: David had remained in normal sinus rhythm for the entire monitoring period. His exercise tolerance had returned, his breathlessness resolved, and he had resumed his football coaching. His anticoagulation was continued for a further three months while the risk of late recurrence was assessed. "The day I ran the length of a pitch without stopping was the day I knew it had worked," he says. His cardiologist noted that the structural changes in his left atrium had partially reversed — a sign that normal rhythm had been restored in time.
Two years after his ablation, David remains in normal rhythm. He attends annual cardiology follow-up, manages his weight and alcohol intake carefully as instructed, and wears a smartwatch that allows him to record a single-lead ECG if he feels any symptoms. He has had one brief recurrence, lasting less than twenty-four hours, which his team managed conservatively. "I feel like I have my life back," he says. "I can work, exercise, and sleep without the constant awareness of my own heartbeat. The Silvaris team took something that was genuinely affecting every aspect of my life and fixed it. I am deeply grateful."

